Analysis of blood markers for early colorectal cancer diagnosis

BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers tha...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastrointestinal oncology Vol. 13; no. 5; pp. 2259 - 2268
Main Authors Bayo Calero, Juan, Castaño López, Miguel Angel, Casado Monge, Pedro Germán, Díaz Portillo, Jacobo, Bejarano García, Ana, Navarro Roldán, Francisco
Format Journal Article
LanguageEnglish
Published AME Publishing Company 01.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers that was efficacious enough to become part of the early diagnosis of CRC. MethodsIn a total of 221 patients who underwent a colonoscopy, two types of markers were identified (I) classic: carcinoembryonic antigen (CEA), CA19.9, α-fetoprotein, CA125, CA72.4, and ferritin; and (II) experimental: neutrophil gelatinase-associated lipocalin (NGAL), estimated glomerular filtration rate (EGFR), 8-hydroxydeoxyguanosine (8OHdG), calprotectin, and cysteine-rich 61 (Cyr61). We divided the patients into four groups according to colonoscopy results: a control group (n=83) with normal colonoscopy, a polyp group (n=56), a CRC group (n=45), and an inflammatory disease group (n=37). We built an algorithm based on multivariate logistic regression analysis. ResultsA total of 51.6% were males, and the median age was 63 years. We designed an algorithm based on the combination of several markers that discriminated CRC patients from the rest of the patients with a performance of 94%, a sensitivity of 95.6%, and a specificity of 80.6%. Discriminating by sex also resulted in two powerful algorithms, although it performed better in males (97% vs. 91%). ConclusionsOur study has devised a predictive model with high efficacy based on the determination of several biomarkers. We think that it could be incorporated into the set of methods used in CRC screening.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID: 0000-0002-6114-4222.
Contributions: (I) Conception and design: J Bayo Calero; (II) Administrative support: J Bayo Calero; (III) Provision of study materials or patients: PG Casado Monge, A Bejarano García; (IV) Collection and assembly of data: MA Castaño López, F Navarro Roldán; (V) Data analysis and interpretation: J Díaz Portillo; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
ISSN:2078-6891
2219-679X
DOI:10.21037/jgo-21-747